These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31476946)

  • 21. Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis.
    Catarino RM; Lopes JD; Forones NM; Parise ER
    Braz J Med Biol Res; 2005 Feb; 38(2):271-6. PubMed ID: 15785839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.
    Lane D; Matte I; Garde-Granger P; Laplante C; Carignan A; Rancourt C; Piché A
    BMC Cancer; 2015 Jul; 15():492. PubMed ID: 26122176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS).
    Farkas B; Boldizsar F; Bohonyi N; Farkas N; Marczi S; Kovacs GL; Bodis J; Koppan M
    J Ovarian Res; 2020 Mar; 13(1):25. PubMed ID: 32138790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis.
    Wang XM; Ma ZY; Song N
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2513-2518. PubMed ID: 29771400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants.
    Menzin AW; Loret de Mola JR; Bilker WB; Wheeler JE; Rubin SC; Feinberg RF
    Cancer; 1998 Jan; 82(1):152-8. PubMed ID: 9428492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of T-helper cytokines in the peritoneal fluid of women with normal ovarian cycle compared with women with chronic anovulation.
    Omu AE; Al-Azemi MK; Makhseed M; Al-Oattan F; Ismail AA; Al-Tahir S; Al-Busiri N
    Acta Obstet Gynecol Scand; 2003 Jul; 82(7):603-9. PubMed ID: 12790840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
    Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
    Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal cytokine level in patients with peritoneal surface malignancies. A study of the RENAPE (French Network for Rare Peritoneal Malignancies).
    Vlaeminck-Guillem V; Bienvenu J; Isaac S; Grangier B; Golfier F; Passot G; Bakrin N; Rodriguez-Lafrasse C; Gilly FN; Glehen O
    Ann Surg Oncol; 2013 Aug; 20(8):2655-62. PubMed ID: 23519518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limits of peritoneal cytokine measurements during abdominal lavage treatment for intraabdominal sepsis.
    Scheingraber S; Bauerfeind F; Böhme J; Dralle H
    Am J Surg; 2001 Apr; 181(4):301-8. PubMed ID: 11438263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does cytokine profiling of aspirate from jaw cysts and tumors have a role in diagnosis?
    Kolokythas A; Karas M; Sarna T; Flick W; Miloro M
    J Oral Maxillofac Surg; 2012 May; 70(5):1070-80. PubMed ID: 21802820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant measurements of interleukin-6 (IL-6) in serum and peritoneal fluid of patients with benign and malignant ovarian tumors.
    Schröder W; Ruppert C; Bender HG
    Eur J Obstet Gynecol Reprod Biol; 1994 Jul; 56(1):43-6. PubMed ID: 7982516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the cytokine profiles of the synovial fluid in a normal temporomandibular joint: preliminary study.
    Kim YK; Kim SG; Kim BS; Lee JY; Yun PY; Bae JH; Oh JS; Ahn JM; Kim JS; Lee SY
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e337-41. PubMed ID: 22425498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines in the peritoneal fluid of patients with endometriosis.
    Koyama N; Matsuura K; Okamura H
    Int J Gynaecol Obstet; 1993 Oct; 43(1):45-50. PubMed ID: 7904954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis.
    Rodríguez-Ramos C; Galan F; Díaz F; Elvira J; Martín-Herrera L; Girón-González JA
    Dig Dis Sci; 2001 Aug; 46(8):1668-76. PubMed ID: 11508666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma.
    Lenzi R; Edwards R; June C; Seiden MV; Garcia ME; Rosenblum M; Freedman RS
    J Transl Med; 2007 Dec; 5():66. PubMed ID: 18076766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of VEGF, IL-8 and beta-FGF concentrations in the serum and ascites of patients with ovarian cancer].
    Sadłecki P; Walentowicz-Sadłecka M; Szymański W; Grabiec M
    Ginekol Pol; 2011 Jul; 82(7):498-502. PubMed ID: 21913426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.
    Santin AD; Bellone S; Ravaggi A; Roman J; Smith CV; Pecorelli S; Cannon MJ; Parham GP
    BJOG; 2001 Aug; 108(8):804-8. PubMed ID: 11510703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acidic ascites inhibits ovarian cancer cell proliferation and correlates with the metabolomic, lipidomic and inflammatory phenotype of human patients.
    Yang Q; Bae G; Nadiradze G; Castagna A; Berezhnoy G; Zizmare L; Kulkarni A; Singh Y; Weinreich FJ; Kommoss S; Reymond MA; Trautwein C
    J Transl Med; 2022 Dec; 20(1):581. PubMed ID: 36503580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.